Addus HomeCare (NASDAQ:ADUS) Sets New 52-Week High at $120.80

Addus HomeCare Co. (NASDAQ:ADUS)’s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $120.80 and last traded at $120.37, with a volume of 25600 shares. The stock had previously closed at $118.78.

Analyst Ratings Changes

Several brokerages have recently commented on ADUS. Oppenheimer increased their price objective on Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research note on Friday, June 7th. Bank of America increased their price objective on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. Stephens increased their price objective on Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a research note on Friday, May 31st. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Finally, TD Cowen increased their price objective on Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a research note on Tuesday, June 18th. One equities research analyst has rated the stock with a sell rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $116.25.

Addus HomeCare Stock Up 0.8 %

The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $2.17 billion, a PE ratio of 29.73, a P/E/G ratio of 2.29 and a beta of 1.01. The stock has a 50-day moving average of $113.33 and a 200 day moving average of $101.18.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. Addus HomeCare’s revenue was up 11.6% on a year-over-year basis. During the same period last year, the business posted $0.84 earnings per share. Sell-side analysts anticipate that Addus HomeCare Co. will post 4.36 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 4.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently bought and sold shares of the company. Louisiana State Employees Retirement System bought a new position in shares of Addus HomeCare in the fourth quarter worth $752,000. Dean Capital Management bought a new position in shares of Addus HomeCare in the fourth quarter worth $652,000. Vanguard Group Inc. boosted its holdings in shares of Addus HomeCare by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after acquiring an additional 38,876 shares during the period. Allianz Asset Management GmbH bought a new position in shares of Addus HomeCare in the fourth quarter worth $5,667,000. Finally, Cetera Trust Company N.A bought a new position in shares of Addus HomeCare in the fourth quarter worth $219,000. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.